Suppr超能文献

伽玛刀放射外科治疗无功能垂体腺瘤的临床及影像学结果

Clinical and Radiologic Outcome of Gamma Knife Radiosurgery on Nonfunctioning Pituitary Adenomas.

作者信息

Bir Shyamal C, Murray Richard D, Ambekar Sudheer, Bollam Papireddy, Nanda Anil

机构信息

Department of Neurosurgery, LSU Health-Shreveport, Shreveport, Louisiana, United States.

出版信息

J Neurol Surg B Skull Base. 2015 Sep;76(5):351-7. doi: 10.1055/s-0035-1549309. Epub 2015 May 8.

Abstract

Objective To elucidate the role of Gamma Knife radiosurgery (GKRS) in the management of nonfunctioning pituitary adenomas (NFAs). Materials and Methods A retrospective review of 57 consecutive patients spanning 2000 to 2013 with NFAs was performed. Of 57 patients, 53 patients had recurrent or residual tumors after microsurgical resection. The study population was evaluated clinically and radiographically after GKRS treatment. The median follow-up time was 45.57 months. Results GKRS in pituitary adenomas showed significant variations in tumor growth control (decreased in 32 patients [56.1%], arrested growth in 21 patients [36.1%], and increased tumor size in 4 patients [7%]). Progression-free survival after GKRS at 3, 7, and 10 years was 100%, 98%, and 90%, respectively. The neurologic signs and symptoms were significantly improved after GKRS (14% versus 107%) compared with pretreated signs and symptoms (p < 0.0001). Five patients (8.8%) required additional treatment. Conclusion Recent follow-up revealed that GKRS offers a high rate of tumor control and preservation of neurologic functions in both new and recurrent patients with NFAs. Thus GKRS is an effective treatment option for recurrent and residual as well as newly diagnosed patients with NFAs.

摘要

目的

阐明伽玛刀放射外科治疗(GKRS)在无功能垂体腺瘤(NFAs)治疗中的作用。材料与方法:对2000年至2013年连续收治的57例NFAs患者进行回顾性研究。57例患者中,53例在显微手术切除后有复发或残留肿瘤。对研究人群在GKRS治疗后进行临床和影像学评估。中位随访时间为45.57个月。结果:垂体腺瘤GKRS治疗后的肿瘤生长控制情况存在显著差异(32例患者[56.1%]肿瘤缩小,21例患者[36.1%]生长停滞,4例患者[7%]肿瘤增大)。GKRS治疗后3年、7年和10年的无进展生存率分别为100%、98%和90%。与治疗前相比,GKRS治疗后神经体征和症状有显著改善(14%对107%)(p < 0.0001)。5例患者(8.8%)需要额外治疗。结论:近期随访显示,GKRS在新发病例和复发的NFAs患者中均能实现较高的肿瘤控制率并保留神经功能。因此,GKRS是复发和残留以及新诊断的NFAs患者的有效治疗选择。

相似文献

2
5
Outcomes and complications of gamma knife radiosurgery for skull base meningiomas.伽玛刀放射外科治疗颅底脑膜瘤的疗效与并发症
J Neurol Surg B Skull Base. 2014 Dec;75(6):397-401. doi: 10.1055/s-0034-1376422. Epub 2014 May 27.
7
Gamma knife radiosurgery for pituitary adenoma: early results.垂体腺瘤的伽玛刀放射外科治疗:早期结果
Neurosurgery. 2003 Jul;53(1):51-9; discussion 59-61. doi: 10.1227/01.neu.0000068702.00330.47.
9
Long-term outcome of gamma knife radiosurgery for vestibular schwannoma.伽玛刀放射外科治疗前庭神经鞘瘤的长期疗效
J Neurol Surg B Skull Base. 2014 Aug;75(4):273-8. doi: 10.1055/s-0034-1371525. Epub 2014 Apr 17.

引用本文的文献

3
Epidemiology of Male Hypogonadism.男性性腺功能减退症的流行病学。
Endocrinol Metab Clin North Am. 2022 Mar;51(1):1-27. doi: 10.1016/j.ecl.2021.11.016. Epub 2022 Feb 8.

本文引用的文献

1
5
Radiotherapy for pituitary adenomas: long-term outcome and complications.垂体腺瘤的放射治疗:长期疗效与并发症
Radiat Oncol J. 2011 Sep;29(3):156-63. doi: 10.3857/roj.2011.29.3.156. Epub 2011 Sep 30.
9
Radiotherapy for pituitary adenomas.
Endocrinol Metab Clin North Am. 2008 Mar;37(1):263-75, xi. doi: 10.1016/j.ecl.2007.10.005.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验